Vectra® is a multi-biomarker molecular blood test that provides an objective and personalized measure of inflammatory disease activity in patients with rheumatoid arthritis.
Vectra demonstrates unsurpassed ability to predict radiographic progression and helps guide personalized medical management decisions to improve patient outcomes.
The Vectra report has been enhanced to include a personalized 1-year risk of rapid radiographic progression. The risk of radiographic progression increases as the patient’s Vectra Score increases.
VectraScore.com // 1-877-743-8639 // Myriad Autoimmune – 320 Wakara Way, Salt Lake City, UT 84108
Vectra is validated for use in adults diagnosed with RA. Test results are intended to aid in the assessment of disease activity in RA patients when
used in conjunction with standard clinical assessment. This test is not intended or validated to diagnose RA. ©2020 Myriad Genetics, Inc. All rights reserved. Myriad, Vectra, VectraView, myVectra, Crescendo Bioscience, and the associated logos are trademarks or registered trademarks of Myriad Genetics, Inc. and its affiliates in the United States and other jurisdictions.